Hu, Yuanming
Xu, Shuang
Li, Boyuan
Inscoe, Christina R.
Tyndall, Donald A.
Lee, Yueh Z.
Lu, Jianping
Zhou, Otto
Funding for this research was provided by:
National Institutes of Health (R56DE030962-01)
North Carolina Biotechnology Center (2021-TRG-6725)
Article History
Received: 14 November 2023
Accepted: 13 February 2024
First Online: 16 February 2024
Competing interests
: The authors declare the following competing interests: O.Z. has equity ownership and serves on the board of directors of XinVisio, LLC., to which the technologies used or evaluated in this project have been licensed, and NuRay Co., Ltd, which manufactures the x-ray sources used in this study. J.L. has equity ownership in XinVisio, LLC. and NuRay Co. Ltd. O.Z., J.L., C.R.I., Y.Z.L., and B.L. are co-inventors of licensed technology evaluated in this study. All activities have been approved by the institutional COI committee. All other authors declare no competing interests.